Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole prolonged-release for dopamine agonist wearing-off in Parkinson's disease
2009-015833-66Phase 4Completed
- Sponsor
- IRCCS San Raffaele Pisana
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropinirole in Parkinson's disease (PD), sponsored by IRCCS San Raffaele Pisana. Primary endpoint: Change from baseline in absolute awake time spent OFF. Started Apr 2012; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-015833-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015833-66.